Projects

A prospective comparative active controlled randomised open labelled multicentre study to compare the safety and efficacy of teriparatide of Enzene Biosciences Ltd Vs Forteo of Eli Lilly on the treatment of postmenopausal osteoporosis

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2017 - 2017

Project Lead

Dr Joe Joseph Cherian

Authors

Dr. Joe Joseph Cherian

Project Status

completed

Project Type

Phase III